🇺🇸 FDA
Patent

US 8105609

Flavivirus immunogens comprising extracellular viral particles composed of the premembrane (prM) and envelope (E) antigens

granted A61KA61K2039/53A61K39/12

Quick answer

US patent 8105609 (Flavivirus immunogens comprising extracellular viral particles composed of the premembrane (prM) and envelope (E) antigens) held by The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention
Grant date
Tue Jan 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K2039/53, A61K39/12, A61K48/00, A61P